| Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues LM Ebert, P Schaerli, B Moser Molecular immunology 42 (7), 799-809, 2005 | 395 | 2005 |
| Homing and function of human skin γδ T cells and NK cells: relevance for tumor surveillance LM Ebert, S Meuter, B Moser The Journal of Immunology 176 (7), 4331-4336, 2006 | 307 | 2006 |
| A skin-selective homing mechanism for human immune surveillance T cells P Schaerli, L Ebert, K Willimann, A Blaser, RS Roos, P Loetscher, ... Journal of Experimental Medicine 199 (9), 1265-1275, 2004 | 256 | 2004 |
| The Regulatory T Cell–Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells LM Ebert, BS Tan, J Browning, S Svobodova, SE Russell, N Kirkpatrick, ... Cancer research 68 (8), 3001-3009, 2008 | 246 | 2008 |
| Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation P Schaerli, K Willimann, LM Ebert, A Walz, B Moser Immunity 23 (3), 331-342, 2005 | 183 | 2005 |
| Chemokines: extracellular messengers for all occasions? LM Gale, SR McColl Bioessays 21 (1), 17-28, 1999 | 161 | 1999 |
| Regulatory T-cell–Mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma T Nicholaou, LM Ebert, ID Davis, GA McArthur, H Jackson, N Dimopoulos, ... Clinical Cancer Research 15 (6), 2166-2173, 2009 | 152 | 2009 |
| Directions in the immune targeting of cancer: lessons learned from the cancer‐testis Ag NY‐ESO‐1 T Nicholaou, L Ebert, ID Davis, N Robson, O Klein, E Maraskovsky, ... Immunology and cell biology 84 (3), 303-317, 2006 | 148 | 2006 |
| Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments SL Perrin, MS Samuel, B Koszyca, MP Brown, LM Ebert, M Oksdath, ... Biochemical Society Transactions 47 (2), 625-638, 2019 | 141 | 2019 |
| Melan-A–specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4 O Klein, LM Ebert, T Nicholaou, J Browning, SE Russell, M Zuber, ... Clinical cancer research 15 (7), 2507-2513, 2009 | 119 | 2009 |
| Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytes LM Ebert, SR McColl The Journal of Immunology 168 (1), 65-72, 2002 | 115 | 2002 |
| A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design LM Ebert, YC Liu, CS Clements, NC Robson, HM Jackson, JL Markby, ... Cancer research 69 (3), 1046-1054, 2009 | 77 | 2009 |
| A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties MR Pitman, JA Powell, C Coolen, PAB Moretti, JR Zebol, DH Pham, ... Oncotarget 6 (9), 7065, 2015 | 74 | 2015 |
| A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma LM Ebert, SE MacRaild, D Zanker, ID Davis, J Cebon, W Chen PloS one 7 (10), e48424, 2012 | 66 | 2012 |
| Lymphocyte traffic control by chemokines: follicular B helper T cells B Moser, L Ebert Immunology letters 85 (2), 105-112, 2003 | 66 | 2003 |
| B cells alter the phenotype and function of follicular‐homing CXCR5+ T cells LM Ebert, MP Horn, AB Lang, B Moser European journal of immunology 34 (12), 3562-3571, 2004 | 64 | 2004 |
| FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis. BS Tan, M Anaka, S Deb, C Freyer, LM Ebert, AC Chueh, S Al-Obaidi, ... Oncotarget 5 (1), 264, 2014 | 59 | 2014 |
| Flt3 ligand expands CD4+FoxP3+ regulatory T cells in human subjects O Klein, LM Ebert, D Zanker, K Woods, BS Tan, J Fucikova, A Behren, ... European journal of immunology 43 (2), 533-539, 2013 | 57 | 2013 |
| Coregulation of CXC chemokine receptor and CD4 expression on T lymphocytes during allogeneic activation LM Ebert, SR McColl The Journal of Immunology 166 (8), 4870-4878, 2001 | 57 | 2001 |
| Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome LY Tan, C Mintoff, MZ Johan, BW Ebert, C Fedele, YF Zhang, P Szeto, ... Oncotarget 7 (29), 46492, 2016 | 49 | 2016 |
